Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

R William Ringo


  • Chief Executive Officer at Five Prime Therapeutics Inc. (FPRX), 2020-03-20
  • at Dermira Inc. (DERM), 2020-02-25
  • Director at Assembly Biosciences Inc. (ASMB), 2019-05-17
  • Director at Immune Design Corp. (IMDZ), 2019-04-04
  • Director at Sangamo Therapeutics Inc (SGMO), 2017-09-22
  • Director at Mirati Therapeutics Inc. (MRTX), 2016-05-19
  • Director at Onyx Pharmaceuticals Inc (ONXX), 2013-10-04
  • Senior Vice President at Pfizer Inc (PFE), 2010-04-01
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ASMB $38.50 1,000 Director 19,465 2018-07-02 Filing
ASMB $42.47 1,000 Director 19,465 2018-06-01 Filing
ASMB $43.06 1,000 Director 19,465 2018-05-01 Filing
ASMB $49.32 1,000 Director 19,465 2018-04-02 Filing
ASMB $56.37 1,000 Director 19,465 2018-03-01 Filing